绥美凯用药指导

It is a new drug used to treat AIDS. It was approved for marketing by the US FDA in 2014 and approved for marketing in my country in 2018. It has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

AIDS is a chronic infectious disease. For patients, medication compliance is very important. Suimeikai is China's first complete single-piece three-in-one preparation with DTG as the core, filling the gap in single-piece compound preparations. Let’s see how to use Suimeikai.

Suimeike is suitable for adults and adolescents (weighing at least 40kg). The recommended dosage is one tablet, once a day. Adults or adolescents whose body weight is less than 40 kg should not be given this product because this product is a fixed-dose tablet and the dose cannot be reduced. If the patient misses a dose of Suimeikan and there are more than 4 hours before the next dose, the patient should take this product as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.

Individual formulations of dolutegravir, abacavir, or lamivudine may be used if discontinuation or dose adjustment of one of the active ingredients is necessary and, in these circumstances, physicians should refer to the respective product information for these medicines.

In addition to the original drug, Suimeikai from Indian Emcure Pharmaceutical Company has also been sold in India. The price is relatively low, and the usage method is the same as the above method. Headquartered in Pune, India, Emcure is a vertically integrated pharmaceutical company with infrastructure, skills and resources on par with the best pharmaceutical companies in the world. Its advantages cover the production and research of APIs, preparations and biotechnology. Therefore, patients do not need to worry about the effects of the Indian version of Suimeikan.

Recommended related hot articles: /newsDetail/87272.html